DIA413.04+5.62 1.38%
SPX5,686.67+82.53 1.47%
IXIC17,977.73+266.99 1.51%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·04/03/2025 12:05:36
Listen to the news

Gainers

  • Protagenic Therapeutics (NASDAQ:PTIX) shares moved upwards by 179.6% to $0.63 during Thursday's pre-market session. The company's market cap stands at $4.5 million. The company's, Q4 earnings came out 3 days ago.
  • Aptevo Therapeutics (NASDAQ:APVO) stock increased by 122.46% to $3.07. The company's market cap stands at $4.4 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock increased by 62.76% to $5.29. The company's market cap stands at $3.2 million.
  • OSR Holdings (NASDAQ:OSRH) stock moved upwards by 44.95% to $2.13. The company's market cap stands at $41.0 million.
  • Genprex (NASDAQ:GNPX) stock increased by 21.08% to $0.36. The company's market cap stands at $3.0 million.
  • Longevity Health Holdings (NASDAQ:XAGE) stock rose 13.64% to $0.15. The market value of their outstanding shares is at $4.5 million.

Losers

  • RxSight (NASDAQ:RXST) stock fell 29.2% to $18.49 during Thursday's pre-market session. The market value of their outstanding shares is at $748.7 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares fell 24.18% to $0.67. The market value of their outstanding shares is at $10.5 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Aldeyra Therapeutics (NASDAQ:ALDX) stock fell 23.01% to $4.1. The market value of their outstanding shares is at $244.1 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock fell 22.95% to $0.23. The company's market cap stands at $4.6 million.
  • ITeos Therapeutics (NASDAQ:ITOS) stock fell 20.11% to $4.61. The market value of their outstanding shares is at $176.0 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock fell 19.56% to $1.81. The market value of their outstanding shares is at $4.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.